IMA Q1 2025 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4M

Operating Income

-$11M

Net Income

-$9M

EPS (Diluted)

$-0.18

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$904,000

Balance Sheet

Total Assets

$131M

Total Liabilities

$13M

Stockholders' Equity

$118M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4M	-$10M	+61.5%
Operating Income	-$11M	-$18M	+40.8%
Net Income	-$9M	-$16M	+46.6%